John Vandermosten

John Vandermosten, CFA

Senior Biotechnology Analyst

John Vandermosten is currently a senior biotechnology research analyst for Zacks Investment Research where he covers a portfolio of small cap biotechnology names. His background includes 19 years of experience in a variety of investment management and research roles across all market cap ranges and throughout the capital structure. John is a frequent moderator of life sciences industry panels and his research articles have been posted extensively on Yahoo Finance News and throughout life sciences social media circles.

Formerly, John was a research analyst for Singular Research covering the health care space and a consultant with Coker Group, a national healthcare services firm providing financial advisory, investment banking, healthcare IT and other services to hospitals and other health care organizations. At Coker Group he consulted with clients in a variety of strategic and financial areas, including asset valuations, due diligence and transactions. Prior to his role as sell-side analyst and consultant, John was a portfolio manager at Westwood Holdings Group and covered health care and other spaces as research analyst. John also worked at the Teacher Retirement System of Texas as investment analyst on the agency’s large cap call overwriting fund.

John has an MBA from Texas A&M University, an MA from Tulane University and a BA from San Diego State University. He has also earned the Chartered Financial Analyst (CFA) designation and is a member of the CFA Society of Dallas.

Follow @vanjohn10

john vandermosten's universe includes